URGN
Urogen Pharma Ltd.
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||
| Capital Expenditures | 289,000 | 295,000 | 194,000 | 254,000 | 752,000 | 1.2M | 325,000 | 560,000 | 271,000 | 695,000 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||
| Free Cash Flow | -162.7M | -97.1M | -76.6M | -87.8M | -85.6M | -107.1M | -71.3M | -37.9M | -9.8M | 3.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — |